A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT05295927 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative Decision

Conditions

Prostatic Neoplasms

Interventions

DRUG: EPI-7386
DRUG: Abiraterone Acetate
DRUG: Prednisone or Prednisolone
DRUG: Apalutamide

Sponsor

Janssen Research & Development, LLC